ABSTRACT The intrinsic apoptotic pathway is essential for murine development. We have previously shown that key mediators of this pathway, such as Bim, Apaf-1 and caspase-3, are down-regulated during the postnatal development of the retina. In this study, we demonstrate that this expression pattern is a feature of other distinct tissues such as the brain, heart and skeletal muscle. Caspase-9 expression is also examined and is shown to follow a different pattern in each tissue. Interestingly, we show that peripheral cells of the internal granular layer of the cerebellum do not down-regulate the intrinsic apoptotic pathway proteins Bim, Apaf-1 or caspase-3. Furthermore, Bim expression is also detectable in the brain stem and the CA3 region of the hippocampus in the adult cerebrum. Finally, we demonstrate that the incidence of TUNEL positive cells in the selected tissues decreases during postnatal development in correlation with the general down-regulation of key apoptotic pathway proteins. In contrast, we also demonstrate that apoptosis persists in the adult thymus and that this tissue continues to express Bim, Apaf-1 and caspase-3 at the same levels as the neonate. In summary, this study shows that a selection of post-mitotic tissues down-regulate key apoptotic proteins, in contrast to the thymus, which requires apoptosis for normal function in early adulthood.
ment of the mouse. This is best illustrated by the caspase-3, -9 and Apaf-1 knock-out models, all of which exhibit perinatal lethality, enlarged brains and craniofacial abnormalities (Kuida et al., 1996 , Cecconi et al., 1998 , Kuida et al., 1998 and Yoshida et al., 1998 . Our group has previously shown that as the murine retina continues to develop postnatally, it downregulates several key proteins of the intrinsic apoptotic pathway as well as pro-apoptotic members of the Bcl-2 family. Bim is the first Bcl-2 family member to be down-regulated and its downregulation correlates with a marked desensitisation of the retina to apoptotic insults. It has been postulated that this may be a defence mechanism employed by the retina to protect against the loss of irreplaceable cells Cotter, 2002 and Donovan et al., 2006) . In this study we examined whether the postnatal down-regulation of intrinsic apoptotic pathway proteins also occurred in other distinct tissues, namely the brain, skeletal muscle and the heart. We also examined the expression of each protein immunohistochemically, in order to determine the regions of each tissue that express the intrinsic apoptotic pathway proteins. Our results demonstrate that Bim, Apaf-1 and caspase-3 are downregulated in the neocortex of the adult brain and in adult skeletal muscle and heart, whereas, the expression of all three proteins is sustained in the IGL of the adult cerebellum and in the adult thymus.
The postnatal developmental expression pattern of intrinsic apoptotic pathway proteins
To determine whether the intrinsic apoptotic pathway is globally down-regulated in adult tissues, we investigated the expres- Immunoblots of brain, skeletal muscle and heart of mice aged between postnatal day (P) 2 and 60 are depicted. Immunoblots were probed with anti-Bim, anti-Apaf-1, anti-caspase-3 and anticaspase-9 antibodies as indicated. Equal loading was confirmed by staining with Ponceau S. The immunoblots depicted are representative of those of three different mice for each tissue for each age group. (B) The TUNEL positive nuclei of each tissue for both age groups were quantified and normalised with respect to the area of each section. Each point represents the mean of six mice +/-standard error. The Student t-Test was performed to calculate the significance of the difference between neonate and adult counts for each tissue; *, p<0.05, **, p<0.01 and ***, p<0.001.
sion of key mediators of this pathway in the brain, heart and skeletal muscle tissue and compared their expression between neonatal and adult mice. As Bim was shown to be particularly potent at inducing cytochrome c release, the apical event of the intrinsic apoptotic pathway (Certo et al., 2006) and we have previously shown that it is down-regulated in the adult retina , we decided to examine its expression in brain, skeletal muscle and heart during postnatal development. Its expression levels peaked at P6 in the brain and in skeletal muscle and at P4 in the heart (Fig. 1A) . It was barely detectable after P10 in all of the tissues examined. We investigated the postnatal expression patterns of Apaf-1 and caspase-3, because they play an essential role in both murine development and the intrinsic apoptotic pathway (Kuida et al., 1996 , Cecconi et al., 1998 , Yoshida et al., 1998 and Slee et al., 2001 . In a similar manner to Bim, both proteins were strongly down-regulated before P15 in each tissue (Fig. 1A) . All three proteins were down-regulated between P10 and P15 in each tissue, with the exception of caspase-3, which was down-regulated in brain, between P8 and P10 and in muscle between P6 and P8. The postnatal developmental expression pattern of all three proteins was strikingly similar to what we have previously observed in the postnatal retina Cotter, 2002 and Donovan et al., 2006) . Our work is supported by other groups that have examined Apaf-1 and caspase-3 expression in brain and skeletal muscle in humans and in various strains of rats and mice (Burgess et al., 1999 , Yakovlev et al., 2001 , Ruest et al., 2002 and Stoka et al., 2006 . However, here we have also extended our study to the heart, thereby demonstrating that the down-regulation of key intrinsic apoptotic pathway mediators occurs in three distinct tissues during postnatal development and that this correlates with a significant reduction in TUNEL positive cells in the adult (Fig. 1B) .
The postnatal developmental expression pattern of caspase-9 was quite different from that of Apaf-1 and caspase-3 and also varied considerably between each tissue (Fig. 1A) . Caspase-9 was markedly down-regulated between P15 and P30 in skeletal muscle. Its expression was also decreased in the heart between P10 and P15, but unlike skeletal muscle, the adult heart continued 
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to express caspase-9 at relatively high levels. Its expression remained unchanged in the brain during postnatal development; this may be due to the presence of glial and other non-neuronal cells in the adult brain. The significance of the sustained expression of caspase-9 in adult brain and heart is unclear, as its activator and its executioner, Apaf-1 and caspase-3 respectively, were markedly down-regulated by P60. However, caspase-9 can also be activated in the absence of Apaf-1 and of cytochrome c release, through the endoplasmic reticulum (ER) stress pathway (Rao et al., 2001 and Morishima et al., 2002, respectively) . As ER stress has been implicated in a number of neurodegenerative diseases and in heart disease, it is possible that sustained caspase-9 expression in the adult brain and heart sensitises these tissues to ER stress (Xu, et al., 2005) . Caspase-9 has also been shown have a role in haematopoiesis in addition to its role in apoptosis (Zermati et al., 2001 , De Botton et al., 2002 and Sordet et al., 2002 . The possibility that caspase-9 may have an alternative function in adult brain and heart is intriguing and merits further investigation. Interestingly, our anti-caspase-9 antibody also cross-reacted with a 43kDa protein, which was dramatically up-regulated during the postnatal development of both heart and muscle. As this protein was larger than any previously described processed fragment of mouse caspase-9, we are currently investigating its identity. We wished to examine whether the down-regulation of caspase-3 and -9 occurred as a result of proteolytical cleavage or at the transcriptional level. To this end, we compared the neonatal expression of caspases-3 and -9 mRNA to that of the adult by RT-PCR. We found that the postnatal developmental expression pattern of caspase-3 mRNA correlated with that of caspase-3 protein in all three tissues, where caspase-3 message was down-regulated markedly in all three adult tissues ( Fig. 2) , indicating that the down-regulation of caspase-3 occurred at the mRNA level, rather than at the protein level. This was further supported by the non-detection of processed caspase-3 fragments by western blot. Interestingly, Ruest and colleagues previously demonstrated that the down-regulation of caspase-3 in rat skeletal muscle occurred at the protein level, rather than at the mRNA level (Ruest et al., 2002) . These contrasting results suggest that the regulation of caspase-3 expression is distinct for different species. The postnatal developmental expression pattern of caspase-9 mRNA in the brain and skeletal muscle correlated with that of caspase-9 protein in both tissues, where caspase-9 mRNA and protein levels remained the same in the adult brain and both caspase-9 mRNA and protein levels decreased in adult skeletal muscle. However, the developmental expression pattern of caspase-9 mRNA did not correlate with that of caspase-9 protein in the heart. While caspase-9 protein levels decreased in the adult, mRNA levels remained the same throughout heart development. Therefore, the decreased caspase-9 expression may be the result of novel proteolytical cleavage of caspase-9, supported by the detection of the 43kDa protein in the adult heart by the anticaspase-9 antibody. Indeed, as the 43kDa protein was also detectable in brain and skeletal muscle, we cannot rule out the possibility that a novel processing of caspase-9 may also occur in both these tissues. However, as there is no concomitant increase in TUNEL positive cells (in fact, the opposite is observed) or in active caspase-3 cleaved products, it appears that any developmental proteolytical cleavage of caspase-9 in adult brain, skeletal muscle or heart tissue is not pro-apoptotic in nature.
An immunohistochemical analysis of intrinsic apoptotic pathway protein expression in neonatal and adult tissue
We have demonstrated a marked down-regulation of Apaf-1, Bim and caspase-3 in distinct tissue types during postnatal development by western blot. While western blot analysis is valid for the measurement of protein expression in the whole tissue, it may preclude detection of the proteins if their expression is sustained in distinct tissue areas or in specific cell-types in the adult tissue. We therefore, also used immunohistochemistry to examine the postnatal developmental expression pattern of Bim, Apaf-1 and caspase-3 in brain, muscle and heart. We demonstrate that Bim, Apaf-1 and caspase-3 all exhibited continuous cytosolic staining throughout neonatal heart in a similar pattern to myosin heavy chain, indicating that neonatal cardiomyocytes expressed all three apoptotic mediators (Fig. 3) . In addition, we also demonstrated the absence of myosin heavy chain in the cells of blood vessels, as expected, whereas these cells did stain positively for all three apoptotic mediators, indicating that Bim, Apaf-1 and caspase-3 expression in the postnatal developing heart is not limited to cardiomyocytes. We also show that Bim, Apaf-1 and caspase-3 were down-regulated throughout the adult heart in correlation with our western blot results, with no apparent retention by any discreet area or specific cell type.
Bim and Apaf-1 expression in neonatal skeletal muscle exhibited a similar pattern to that of myosin heavy chain, indicating that neonatal myofibres expressed both apoptotic mediators (Fig. 3) . We could not detect the expression of either protein in adult skeletal muscle in correlation with our western blot results, indicating that neither protein was retained by any discreet area or specific cell type. Interestingly, the expression pattern of caspase-3 in neonatal skeletal muscle exhibited a different pattern to that of Bim and Apaf-1 and, indeed, myosin heavy chain. Caspase-3 immunostaining was punctuate and seemed to localise around nuclei, suggesting that caspase-3 is localised in the nucleus of neonatal skeletal muscle, which has been previously observed in Fig. 2 . The expression of caspase-3 and -9 mRNA in neonatal (P6, left colums) and adult (P60 right columns) tissue. RT-PCR analysis was performed to detect the expression levels of caspase-3 and -9 in tissue of the neonate and the adult. Total RNA was purified from brain, skeletal muscle and heart taken from P6 and P60 mice and converted to cDNA by reverse transcription. The subsequent cDNA was amplified using oligonucleotide primers specific for caspase-3, -9 and 18S rRNA. The PCR products were analysed by electrophoresis through a 1.5% agarose gel and visualised by ethidium bromide staining.18S rRNA expression was used as a loading control. other systems, (Mandal et al., 1999 , Noyan-Ashraf et al., 2005 , Ramuz et al., 2003 . Alternatively, the caspase-3 expression pattern is also suggestive of specific caspase-3 expression by differentiating myoblasts in the developing muscle, as caspase-3 activity is required for myoblast differentiation (Fernando et al., 2002) . In addition, we demonstrated that caspase-3 was downregulated in the adult tissue in correlation with our western blot results.
Bim, Apaf-1 and caspase-3 were detectable in the neocortex and the developing cerebellum of the neonatal brain (Fig. 4A) . The staining pattern of all three proteins in the neocortex strongly resembled that of NeuN, a neuron-specific marker, in serial sections, suggesting that neonatal neocortical neurons express all three apoptotic mediators. In support of this, higher magnification revealed that Bim, Apaf-1 and caspase-3 positive cells exhibited similar morphology to that of NeuN positive neurons. However, we were also able to detect caspase-3 in cellular processes outside of cell bodies in a similar pattern to that of glial fibrillary acidic protein (GFAP), a glial cell marker, suggesting that caspase-3 was also expressed by neonatal glial cells. We could not detect the expression of Bim, Apaf-1 or caspase-3 in the neocortex of adult mice in correlation with our western blot results, P6 P60 Heart Fig. 3 . Immunohistochemical analysis of intrinsic apoptotic pathway protein expression in neonatal and adult heart and skeletal muscle tissue. Longitudinal sections of thigh muscle and heart taken from P6 and P60 mice were probed with antibodies directed against Bim, Apaf-1 and caspase-3 and, where positive, an antibody that detects cardiac and skeletal muscle heavy chain myosin, as indicated. As neonatal sections of both heart and skeletal muscle were positive for each apoptotic protein, serial sections were probed for Bim, Apaf-1, caspase-3 and myosin heavy chain using blood vessels for orientation. All images were taken at 40X and the inserts depict expanded images of the centre blood vessels. Heart and skeletal muscle tissue was taken from three different mice at each age and at least five fields of each tissue were examined at 40X for positive staining; the depicted images are representative of all examined fields.
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which demonstrated the down-regulation of all three apoptotic mediators in the whole brain. We also examined the expression patterns of all three mediators in the neonatal cerebellum (Fig.  4B ). Apaf-1 and caspase-3 exhibited similar staining patterns and were detectable in the external granular layer (EGL), the molecular layer and the IGL, whereas Bim was only detectable in the EGL and on the external margin of the IGL. Detection of all three mediators in both granular layers in conjunction with NeuN staining suggests that neonatal granule neurons express all three apoptotic mediators; however, the positive staining of both layers by GFAP suggests that cerebellar glial cells may also express Bim, Apaf-1 and caspase-3. Surprisingly, we were also able to detect Bim, Apaf-1 and caspase-3 in the IGL of the adult cerebellum. We specifically detected each protein in a layer of cells on the external margin of the IGL. Given that Purkinje cells are present in this region of the cerebellum, we stained serial sections with the Purkinje-specific marker, calbindin, along with NeuN, which does not detect Purkinje cells (Mullen et al., 1992) were positive for each apoptotic protein, serial sections of the neocortex were probed for Bim, Apaf-1 and caspase-3 followed by the neuron-specific marker NeuN and the glial cell-specific marker GFAP. The positive staining of a particular cortical layer by antibodies directed against the apoptotic proteins, which correlated strongly with NeuN staining is indicated by an arrow. Images were initially taken at 10X, but where positive staining occurred, images were taken of the centre of each 10X field at 40X to demonstrate the morphology of positively stained cells. (B) The immunostaining of neonatal and adult cerebellum is depicted. As both neonatal and adult cerebellum stained positively for Bim, Apaf-1 and caspase-3, serial sections of each age were probed for these apoptotic proteins as well as NeuN and GFAP. Additionally, as the morphology of cells positive for all three apoptotic proteins in the adult cerebellum strongly resembled that of Purkinje cells, the adult cerebellum was additionally probed with the Purkinje cell-specific marker, calbinden. All images were taken at 40X, where positively stained cells of the adult cerebellum indicated by arrow heads were expanded to demonstrate their morphology. Brains were taken from three different mice at each age and the entire neocortex, as well as the entire cerebellum of each brain were examined for positive staining at 10X; the depicted images are representative of all examined fields. Abbreviations: E, external granular layer; ML, molecular layer; I, internal granular layer.
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that the expression of each protein in the adult cerebellum is Purkinje cell-specific. Two studies published in 2006 reported a susceptibility of cells of the IGL to forebrain injury, however, only one of these studies could detect evidence of apoptosis (Park et al., 2006 and Taylor et al., 2006) . It would be interesting to investigate the nature of the IGL's sensitivity to forebrain injury in light of our results. We also demonstrate that Bim expression exhibited a similar pattern to that of NeuN in the adult brain stem and the CA3 region of the adult hippocampus (Fig. 4) , 2005) ; its expression in adult brain cells may therefore sensitise them to certain apoptotic stimuli. An examination of the cells that express Bim in the adult brain may provide an insight into Bim's role in the adult cerebrum, particularly in the CA3, which has been shown to be especially sensitive to brain trauma, protein hyperphosphorylation and endocrine-disruption, (Mizuhashi et al., 2000 , Runden et al., 1998 , Tashlykov et al., 2007 .
The intrinsic apoptotic pathway in the thymus Adult brain, muscle and heart are mainly composed of terminally differentiated cells. We wished to compare these tissues with a tissue that would still contain developing cells in early adulthood, such as the thymus, where the development of Images taken at 10X of serial sections of brain stem probed with Bim and NeuN using the cerebellum (Cb) for orientation are depicted. The indicated area of each serial section was expanded and depicted on the right in order to demonstrate the morphology of positively stained cells. Brains taken from three different adult mice and at least five 10X fields of the brain stem of each brain were examined for positive staining, where these fields were also examined at 40X to confirm neuronal morphology; the depicted images are representative of all examined fields. (B) Positive Bim staining of the CA3 region of the hippocampus is depicted at 10X. Images taken at 40X of the CA3 region serially stained for Bim and NeuN are also depicted as indicated. The adult CA3 region of three different mice was examined for positive staining at 10X, where the CA3 was also examined at 40X to confirm neuronal morphology; the depicted images are representative of all examined CA3 regions. and P60 mice are stained with Hoechst 33342 (blue) and TUNEL (green). Thymi were taken from three different mice of each age and at least five fields were examined at 40X for TUNEL staining; the depicted images are representative of all examined fields. (B) Immunoblots of thymi taken from P10 and P60 mice are depicted. The immunoblots were probed with anti-Bim, anti-Apaf-1, anti-caspase-9 and anti-caspase-3 antibodies as indicated. Equal loading was confirmed using Ponceau S.
the T-cell repertoire continues through adolescence up to early adulthood. Bim is essential for negative selection in the thymus (Villunger et al., 2004) and caspase-3 is required for the activation-induced cell death of mature T-cells after infection . In contrast to brain, muscle and heart, the intrinsic apoptotic pathway proteins, Bim, Apaf-1 and caspase-3 were not down-regulated in the adult thymus (Fig. 4B) . Caspase-9 expression was similarly sustained from neonate to adulthood. Additionally, there was no apparent decrease in TUNEL positive cells in the adult thymus compared to the neonate (Fig. 4A) . The presence of apoptotic cells at both ages would be attributable to the developmental processes of positive and negative selection of the developing thymocytes. While the sustained expression of key apoptotic mediators by the adult thymus is required for normal tissue function, developmental apoptosis is complete in adult brain, muscle and heart and the developmental role of these mediators is no longer be required. Furthermore, the down-regulation of said apoptotic mediators may serve to protect adult brain, heart and skeletal muscle against irreplaceable cell loss.
We showed that there is a general down-regulation of key apoptotic proteins in brain, muscle and heart. Interestingly, our immunohistochemical study revealed that key mediators of the intrinsic apoptotic pathway were not down-regulated in the IGL of the cerebellum and that individual adult brain cells expressed Bim in the brainstem and in the CA3 region of the hippocampus. There is a large body of evidence implicating apoptosis in disorders and injuries of the adult brain, heart and skeletal muscle (Mattson, 2000 , Gill et al., 2002 and Tews, 2005 . It is possible that the sustained global expression of caspase-9 in brain and heart and the expression of Bim in the adult cerebrum could contribute to these traumas and disorders. There is also evidence that the down-regulated intrinsic apoptotic pathway proteins can be up-regulated in response to injury; Apaf-1 and caspase-3 are re-expressed following traumatic brain injury in the rat (Yakovlev et al., 2001) and caspase-3 is re-expressed in skeletal muscle following muscle-fibre damage (Ruest et al., 2002) . Our group has also reported the apparent re-expression of caspase-3 in the ganglion cell layer of the retina in a model of glaucoma . We are also currently investigating the molecular mechanisms of the developmental down-regulation of Apaf-1 and caspase-3 in the whole retina and have described the role of histone deacetylase in the regulation of their expression during development (Wallace et al., 2006) . Elucidation of the molecular mechanisms of intrinsic apoptotic protein developmental down-regulation and re-expression following disease or injury, would lead to a greater understanding of apoptosis and of the pathological conditions that effect adult tissue and may even provide therapeutic targets.
Experimental Procedures
Western Blot analysis
Tissue was harvested from Balb/c mice of random sex and was washed with cold PBS. Excised tissue was cut into pieces with scissors and homogenised in cold RIPA buffer (10mM Tris-HCl pH 7.5, 150mM NaCl, 1% Triton-X 100, 0.1% SDS, 1mM EDTA pH 8, 0.2mM AEBSF, 1 X protease cocktail inhibitor [Roche Diagnostics Ltd., East Sussex, United Kingdom]). Lysate total protein was determined using the BioRad protein assay (Bio-Rad, Hemel Hempstead, UK). SDS PAGE and western blot analysis were performed as standard. Anti-Apaf-1 antibody (Apotech Corporation, Epalinges, Switzerland) was used at a dilution of 1:500, anti-caspase-3 antibody and anti-caspase-9 antibodies (Cell Signalling Technology, MA, USA) were used at dilutions of 1:500 and 1:1,000 respectively and anti-Bim antibody (Sigma, Dublin, Ireland) was used at a dilution of 1:500.
RT-PCR
Total RNA was isolated from excised tissue at each age using reagent according to the manufacturer's conditions (TriReagent; Molecular Research Centre, OH, US). This was then treated with DNase (Promega, WI, US) at 1 unit DNase/µg RNA at 37ºC for 30min and subsequently reverse transcribed to cDNA using M-MLV reverse transcriptase (2.5 U/µl) (Promega) and 5 µM random decamers (Ambion, TX, US). Products were amplified with the use of 0.05 U/µL polymerase (Taq; Promega). To ensure linear signals, all products were optimized for cycle number and product amplification. Equal loading was achieved using 18S rRNA as a loading control. Primers (0.33 pmol/µl) used were as follows: caspase-3 forward, 5' GACTGTGGC ATTGAGACAGAC 3'; reverse, 5' TTTGCGTGGAAAGTGGAGTCC 3'; caspase-9 forward, 5' GCTTCTCTGCCACTGTACTACTGA 3'; reverse, 5' GGAAGAATTAGCCCTTCTGGTAAC 3'; 18S rRNA forward, 5' CGAGGCCCTGTAATTGGA 3'; reverse, 5' GTTTCCCGTGTTGAGTCA 3'. PCR products were separated on a 1.5% agarose gel, stained with ethidium bromide and visualized under UV light.
Immunohistochemistry
Excised tissue (also from Balb/c mice) was fixed in 10% buffered formalin for at least 24 hours, cryo-protected by overnight incubation in 30% sucrose, embedded in tissue freezing medium (Shandon, MA, U.S.) and 5-7 µm cryo-sections were taken. Antigen was retrieved using 10mM Citrate (pH 6), after which, endogenous peroxidases were quenched in H 2 O 2 (0.3% in 70% ethanol). The cryo-sections were then blocked in 5% Goat Serum (Sigma) in PBS and subsequently incubated with primary antibody overnight at 4ºC. After the primary antibody was washed off, the sections were incubated with biotinylated secondary antibody (Vector Laboratories, CA, US). Antigen was detected with a stain kit and substrate (VectaStain Elite ABC and DAB substrate kit; Vector Laboratories). The cryo-sections were then counterstained with Hematoxylin (Sigma) and mounted with DPX (BDH, Poole, UK). AntiApaf-1 antibody (Apotech Corporation) was used at a dilution of 1:100 and anti-caspase-3 and anti-Bim antibodies (Cell Signalling Technology) were used at dilutions of 1:100 and 1:400 respectively. Antimyosin heavy chain antibody (Abcam, Cambridge, UK) was used at a dilution of 1:100, anti-NeuN antibody (Chemicon, Hampshire, UK) was used at a dilution of 1:300, anti-GFAP (DakoCytomation, Glastrup, Denmark) antibody was used at a dilution of 1:500 and anti-calbindin antibody (Sigma) was used at a dilution of 1:200. All images were taken with a Nikon DMX 1200 camera (Nikon Tokyo, Japan).
TUNEL labelling
Cryo-sections (5-7 µm) were made permeable by incubation in 0.1% Triton-X/PBS for 2 min and were subsequently incubated with TUNEL reaction mixture (recombinant 0.6 unit/µl Terminal Deoxynucleotidyl Transferase and 1X reaction buffer [Promega Corporation, WI, U.S.], 3 µM fluorescein-12-dUTP, [Roche Diagnostics Ltd.] and Hoechst 33342 [Sigma] ) for 1 h at 37ºC. The cryo-sections were then washed and mounted using Mowiol (Calbiochem, WI, US). Slides were then observed using fluorescence microscopy (Leica Microsystems GmbH, Wetzlar, Germany) equipped with a Nikon DMX 1200 camera (Nikon). All images were taken at 40X magnification.
